Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
about
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as TherapyTreatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study).A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Treatment-resistant depression in primary care across CanadaAdjuvant valproate therapy for patients with suspected mixed-depressive featuresAntidepressant treatment for acute bipolar depression: an update.Bipolar disorder: the shift to overdiagnosis.Bipolar disorder diagnosis: challenges and future directions.Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.Identification and management of cryptic bipolarity in patients with TRD.Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trialEffect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.Clinical characteristics of patients assessed within an Improving Access to Psychological Therapies (IAPT) service: results from a naturalistic cohort study (Predicting Outcome Following Psychological Therapy; PROMPT).The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression.A Case of Major Depressive Disorder With Mixed Features: Diagnostic and Treatment Issues.Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study.A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression.Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care serviceTherapeutic options in treatment-resistant depression.Overview of antidepressant treatment of bipolar depression.Getting depression clinical practice guidelines right: time for change?Brain stimulation treatments in bipolar disorder: A review of the current literature.Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.Evaluation of the 13-item Hypomania Checklist and a brief 3-item manic features questionnaire in primary care.Bipolar disorders in DSM-5: strengths, problems and perspectives.Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.
P2860
Q26773084-7598C986-6F31-43C6-AAD0-790A20F67266Q31106370-93DEB81E-79C5-47AC-BE28-BC73CB4709AFQ33658525-531B2EEC-26EF-403A-B9F2-654133ED1AD2Q33861601-10D782F4-7271-4D56-81C3-359227A2C5F3Q33925111-FB73AA0F-4EB7-4A3F-B30A-DB6CB8058E73Q34154885-B6B570BD-B96C-4C47-93F2-F0D1000EE318Q34311476-A5A769C3-6362-4185-9661-3C0660F4F4D7Q34344078-CA224398-2A1A-48AA-8253-6E44097E5A7AQ34389967-B32619A2-FA21-439D-8C73-2FD2D13E0EEFQ34601322-814725DA-D6DE-46DC-94CA-F6697E406803Q35789318-17C3B9BB-31F4-4037-A760-8895D53415F3Q35886579-F0ED0F50-A0FB-4892-AED1-41CD5E502907Q35937863-771D6208-62B4-49F3-99A3-CCCC120C6520Q35952732-DA6253E7-6F8F-4F52-AE19-9F1CE665836AQ36332560-DD513C9A-5829-4D7B-979C-6A00E668D274Q36752062-D4E4C701-F013-4BD3-A778-7119A57D6FE3Q36908442-417A676F-272E-4326-A865-943F6FEB7B6EQ37115466-EC2B62EF-795B-49C7-8D98-B5B987FB4B89Q37881968-17AA4FCE-5D84-4710-AB87-8707D894A254Q38083305-5569623F-3B2B-4DF4-9858-45FE78314204Q38126094-3D35C75A-90E2-4083-977F-4E992F33D973Q38282518-6552C5E8-58F0-4EC4-869F-9F102E80CD09Q38758414-2567B96F-8821-4D57-B021-EED456E0D703Q41193622-73183B2B-2923-4173-B5F1-B1B10E4D8D67Q41692261-F69A25BD-6FCC-4074-9ECB-D48454B2D6F3Q47140935-F76D24D5-0045-441D-8808-F7E1974C9917Q47648526-4082DD90-2216-4B1A-8FDD-CA32B7D8C60CQ48682021-D5764503-AAC8-4121-B6AC-3CD15F821DC7
P2860
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is unrecognized bipolar disord ...... reatment resistant depression?
@en
Is unrecognized bipolar disord ...... reatment resistant depression?
@nl
type
label
Is unrecognized bipolar disord ...... reatment resistant depression?
@en
Is unrecognized bipolar disord ...... reatment resistant depression?
@nl
prefLabel
Is unrecognized bipolar disord ...... reatment resistant depression?
@en
Is unrecognized bipolar disord ...... reatment resistant depression?
@nl
P2093
P1476
Is unrecognized bipolar disord ...... reatment resistant depression?
@en
P2093
P356
10.1016/J.JAD.2010.06.036
P577
2010-07-23T00:00:00Z